Galectin-1 exerts inhibitory effects during DENV-1 infection

Autor: Camillo Del Cistia Andrade, Marcelo Dias-Baruffi, Thalita B. Riul, Karina Alves Toledo, Sean R. Stowell, Raquel Rinaldi Russo, Richard D. Cummings, Renata Tomé Alves, Victor Hugo Aquino, Marise Lopes Fermino, Vanessa Danielle Menjon Muller
Přispěvatelé: Universidade Estadual Paulista (Unesp)
Rok vydání: 2014
Předmět:
Viral Diseases
Galectin 1
Galectin 3
viruses
Glycobiology
lcsh:Medicine
Pathogenesis
Dengue virus
Pathology and Laboratory Medicine
medicine.disease_cause
Biochemistry
Dengue Fever
Dengue fever
Dengue
Mice
Medicine and Health Sciences
lcsh:Science
Multidisciplinary
Cell Death
biology
Flow Cytometry
Recombinant Proteins
Infectious Diseases
Host-Pathogen Interactions
Viral load
Research Article
Neglected Tropical Diseases
Cell Survival
Carbohydrates
Enzyme-Linked Immunosorbent Assay
Mice
Transgenic

CARBOIDRATOS
Microbiology
Antiviral Agents
Virus
Cell Line
Immune system
In vivo
Virology
medicine
Animals
Humans
Cell Lineage
Antibody-dependent enhancement
Macrophages
Host Cells
lcsh:R
Biology and Life Sciences
RNA virus
Dengue Virus
Tropical Diseases
biology.organism_classification
medicine.disease
Viral Replication
Mice
Inbred C57BL

Animal Models of Infection
lcsh:Q
Adsorption
Viral Transmission and Infection
Zdroj: Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Currículo Lattes
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
PLoS ONE, Vol 9, Iss 11, p e112474 (2014)
PLoS ONE
Popis: Made available in DSpace on 2015-08-21T17:53:06Z (GMT). No. of bitstreams: 0 Previous issue date: 2014 Dengue virus (DENV) is an enveloped RNA virus that is mosquito-transmitted and can infect a variety of immune and non-immune cells. Response to infection ranges from asymptomatic disease to a severe disorder known as dengue hemorrhagic fever. Despite efforts to control the disease, there are no effective treatments or vaccines. In our search for new antiviral compounds to combat infection by dengue virus type 1 (DENV-1), we investigated the role of galectin-1, a widely-expressed mammalian lectin with functions in cell-pathogen interactions and immunoregulatory properties. We found that DENV-1 infection of cells in vitro exhibited caused decreased expression of Gal-1 in several different human cell lines, suggesting that loss of Gal-1 is associated with virus production. In test of this hypothesis we found that exogenous addition of human recombinant Gal-1 (hrGal-1) inhibits the virus production in the three different cell types. This inhibitory effect was dependent on hrGal-1 dimerization and required its carbohydrate recognition domain. Importantly, the inhibition was specific for hrGal-1, since no effect was observed using recombinant human galectin-3. Interestingly, we found that hrGal-1 directly binds to dengue virus and acts, at least in part, during the early stages of DENV-1 infection, by inhibiting viral adsorption and its internalization to target cells. To test the in vivo role of Gal-1 in DENV infection, Gal-1-deficient-mice were used to demonstrate that the expression of endogenous Galectin-1 contributes to resistance of macrophages to in vitro-infection with DENV-1 and it is also important to physiological susceptibility of mice to in vivo infection with DENV-1. These results provide novel insights into the functions of Gal-1 in resistance to DENV infection and suggest that Gal-1 should be explored as a potential antiviral compound. Universidade Estadual Paulista Júlio de Mesquita Filho, Faculdade de Ciências e Letras de Assis, Assis, Avenida Dom Antonio, 2100, Parque Universitário, CEP 19806900, SP, Brasil Universidade Estadual Paulista Júlio de Mesquita Filho, Faculdade de Ciências e Letras de Assis, Assis, Avenida Dom Antonio, 2100, Parque Universitário, CEP 19806900, SP, Brasil
Databáze: OpenAIRE